2022 Conference Presentations
Targeted Immunotherapy- The New Arsenal in the Treatment of Pediatric Leukemia
2 Course Meal Past, Present & Future for CINV FDA Approval Process/Primer
What’s New in Pediatric Brain Tumor
Navigating the Shifting Sands of Covid Treatment
Inclusive Leadership in Healthcare
New Therapies in Sickle Cell Disease
The Past, Present, and Future of Chimeric Antigen Receptor Therapy
The Next Chapter…The Journey of Survivorship from End of Therapy to Long Term Follow Up